Features | Partner Sites | Information | LinkXpress
Sign In
JIB
BioConferenceLive
GLOBETECH PUBLISHING

Hydrogels Assessed for Biomedical Uses

By BiotechDaily International staff writers
Posted on 16 Jul 2013
Image: Agar/PAM DN hydrogels show extraordinary mechanical and free-shapeable properties: (a) bending; (b) knotting; (c) compression; (d) (stretching); (e) hexagon; (f) teddy bear gel under compression; and (g) teddy bear gel after force release (Photo courtesy of Qiang Chen and Chao Zhao).
Image: Agar/PAM DN hydrogels show extraordinary mechanical and free-shapeable properties: (a) bending; (b) knotting; (c) compression; (d) (stretching); (e) hexagon; (f) teddy bear gel under compression; and (g) teddy bear gel after force release (Photo courtesy of Qiang Chen and Chao Zhao).
Scientists are studying hydrogel, a hydrophilic polymer chain with similar flexibility to natural tissue, for new biomedical uses.

Dr. Jie Zheng, associate professor of chemical and biomolecular engineering, and Dr. Robert Weiss, a professor and chair of polymer engineering at the University of Akron (OH, USA), are among the most recent to add to the mounting research of hydrogels, the gelatinous substance that, because of its toughness and plasticity, has several biomedical applications, including cartilage repair, implants for minimally invasive surgery and drug delivery.

Because, as Dr. Zheng reported, “all existing methods to prepare double-network hydrogels involve multiple-step processes, which are tedious and time-consuming.” Dr. Zheng and his team developed a simple, effective, and one-pot technique (in which reactions occur in one as opposed to several pots) to synthesize double-network hydrogels—that is, hydrogels composed of two networks of polymer chains, one rigid, the other ductile.

Dr. Zheng not only made the synthesis of these hydrogels more effective but also made the hydrogels tougher. Most hydrogels are weak and brittle, “suffering from low mechanical strength, poor toughness, and/or limited extensibility and recoverability,” Dr. Zheng remarked. His hydrogels, however, “exhibit high mechanical properties, excellent recoverable properties, and a unique, free-shapeable property,” he stated, making them potential replacements for load-bearing soft tissues such as muscle, cartilage, tendon, and blood vessels.

Dr. Weiss also has synthesized a more resilient brand of hydrogel, a shape memory hydrogel, which can be curved and stretched and fixed into temporary shapes. When exposed to an external stimulus, such as temperature, light, moisture, or an electric field, shape memory polymers recover their original, permanent shape.

Dr.Weiss’s shape memory hydrogels are thermally actuated, so that they stretch and change shape when heated, and they retain this temporary shape when cooled. Biocompatible, shape memory hydrogels have the potential to be used for minimally invasive surgery and drug delivery, Dr. Weiss noted. “Shape memory may be useful for deployment of hydrogels in biomedical applications using less invasive methods ... for example, one can implant a compact form of the device that would deploy into the usable shape after it is implanted,” he said.

A small form of the shape memory hydrogel may be inserted into the body, for instance, where, upon absorbing bodily fluids, it expands into the chosen shape of the implant, thereby filling a wound or replacing tissue. The permeable hydrogels can also be packed with drugs and positioned into the body, where the sponge-like gel biodegrades and releases the drugs from its pores.

The researchers published their findings January 7, 2013, in the journal ACS Macro Letters. Dr. Zheng’s application has received provisional approval for a patent, and his article, coauthored by Zheng and his UA research colleagues, Drs. Qiang Chen, Lin Zhu, Chao Zhao, and Qiuming Wang, was published June 14, 2013, online in the journal Advanced Materials.

Related Links:

University of Akron



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: In the liver tissue of obese animals with type II diabetes, unhealthy, fat-filled cells are prolific (small white cells, panel A). After chronic treatment through FGF1 injections, the liver cells successfully lose fat and absorb sugar from the bloodstream (small purple cells, panel B) and more closely resemble cells of normal, non-diabetic animals (Photo courtesy of the Salk Institute for Biological Studies).

Fibroblast Growth Factor 1 Treatment Restores Glucose Control in Mouse Diabetes Model

A "vaccine" based on the metabolic regulator fibroblast growth factor 1 (FGF1) removed the insulin resistance that characterizes type II diabetes and restored the body's natural ability to manage its glucose... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Business

view channel

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 (corresponding to 23.8% annual growth) in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research. This notable growth... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.